We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Appellate Court Upholds Six-Month Waiting Period for Biosimilar Launches
Appellate Court Upholds Six-Month Waiting Period for Biosimilar Launches
In a blow to the biosimilars industry, the federal appellate court has reiterated its position that biosimilars makers must give reference product holders six months’ notice before going to market.